SEC 13F Intelligence

Glenmede Trust Co Na / PFE

Glenmede Trust Co Na’s Pfizer Inc Position

Does Glenmede Trust Co Na own Pfizer Inc (PFE)? Yes — 902.0K shares worth $25M (+0.12% of its 13F portfolio) as of Q1 2026, down from 955.2K shares the prior filed quarter.

Position Value
$25M
Q1 2026
Shares
902.0K
% of Portfolio
+0.12%
Quarters Held
28
currently held

Position History PFE

Reported value by quarter
Q4 ’18: $223MQ4 ’18Q1 ’19: $168MQ2 ’19: $195MQ3 ’19: $98MQ4 ’19: $132MQ4 ’19Q1 ’20: $132MQ2 ’20: $94MQ3 ’20: $115MQ4 ’20: $128MQ4 ’20Q1 ’21: $98MQ2 ’21: $95MQ3 ’21: $102MQ4 ’21: $142MQ4 ’21Q1 ’22: $137MQ2 ’22: $140MQ3 ’22: $99MQ4 ’22: $119MQ4 ’22Q1 ’23: $87MQ2 ’23: $87MQ3 ’23: $53MQ4 ’23: $39MQ4 ’23Q1 ’24: $30MQ2 ’24: $31MQ3 ’24: $31MQ4 ’24: $23MQ4 ’24Q1 ’25: $21MQ4 ’25: $24MQ1 ’26: $25Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026902.0K$25M+0.12%
Q4 2025955.2K$24M+0.11%
Q1 2025834.3K$21M+0.11%
Q4 2024859.1K$23M+0.12%
Q3 20241.07M$31M+0.15%
Q2 20241.10M$31M+0.16%
Q1 20241.08M$30M+0.15%
Q4 20231.36M$39M+0.20%
Q3 20231.60M$53M+0.30%
Q2 20232.14M$87M+0.49%
Q1 20232.14M$87M+0.49%
Q4 20222.32M$119M+0.70%
Q3 20222.26M$99M+0.62%
Q2 20222.68M$140M+0.82%
Q1 20222.65M$137M+0.67%
Q4 20212.41M$142M+0.68%
Q3 20212.37M$102M+0.53%
Q2 20212.43M$95M+0.49%
Q1 20212.70M$98M+0.53%
Q4 20203.47M$128M+0.70%
Q3 20203.12M$115M+0.69%
Q2 20202.89M$94M+0.58%
Q1 20203.37M$132M+0.60%
Q4 20193.37M$132M+0.60%
Q3 20192.74M$98M+0.45%
Q2 20194.49M$195M+0.85%
Q1 20193.95M$168M+0.76%
Q4 20185.10M$223M+1.09%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Glenmede Trust Co Na’s full portfolio or all institutional holders of PFE.